Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1975 1
1977 1
1980 1
1988 1
2002 1
2004 2
2006 1
2010 1
2011 3
2012 2
2013 1
2014 4
2015 5
2016 3
2017 1
2018 2
2019 2
2020 2
2021 8
2022 6
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.
Provencio M, Nadal E, González-Larriba JL, Martínez-Martí A, Bernabé R, Bosch-Barrera J, Casal-Rubio J, Calvo V, Insa A, Ponce S, Reguart N, de Castro J, Mosquera J, Cobo M, Aguilar A, López Vivanco G, Camps C, López-Castro R, Morán T, Barneto I, Rodríguez-Abreu D, Serna-Blasco R, Benítez R, Aguado de la Rosa C, Palmero R, Hernando-Trancho F, Martín-López J, Cruz-Bermúdez A, Massuti B, Romero A. Provencio M, et al. Among authors: martin lopez j. N Engl J Med. 2023 Aug 10;389(6):504-513. doi: 10.1056/NEJMoa2215530. Epub 2023 Jun 28. N Engl J Med. 2023. PMID: 37379158 Clinical Trial.
Candidiasis (vulvovaginal).
Martin Lopez JE. Martin Lopez JE. BMJ Clin Evid. 2015 Mar 16;2015:0815. BMJ Clin Evid. 2015. PMID: 25775428 Free PMC article. Review.
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial).
Provencio M, Serna-Blasco R, Nadal E, Insa A, García-Campelo MR, Casal Rubio J, Dómine M, Majem M, Rodríguez-Abreu D, Martínez-Martí A, De Castro Carpeño J, Cobo M, López Vivanco G, Del Barco E, Bernabé Caro R, Viñolas N, Barneto Aranda I, Viteri S, Pereira E, Royuela A, Calvo V, Martín-López J, García-García F, Casarrubios M, Franco F, Sánchez-Herrero E, Massuti B, Cruz-Bermúdez A, Romero A. Provencio M, et al. Among authors: martin lopez j. J Clin Oncol. 2022 Sep 1;40(25):2924-2933. doi: 10.1200/JCO.21.02660. Epub 2022 May 16. J Clin Oncol. 2022. PMID: 35576508 Free PMC article. Clinical Trial.
Imatinib in COVID-19: hope and caution.
Bernal-Bello D, Morales-Ortega A, Isabel Farfán-Sedano A, de Tena JG, Martín-López JVS. Bernal-Bello D, et al. Among authors: martin lopez jvs. Lancet Respir Med. 2021 Sep;9(9):938-939. doi: 10.1016/S2213-2600(21)00266-6. Epub 2021 Jun 18. Lancet Respir Med. 2021. PMID: 34147143 Free PMC article. No abstract available.
Linker domain function predicts pathogenic MLH1 missense variants.
London J, Martín-López J, Yang I, Liu J, Lee JB, Fishel R. London J, et al. Among authors: martin lopez j. Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):e2019215118. doi: 10.1073/pnas.2019215118. Proc Natl Acad Sci U S A. 2021. PMID: 33619096 Free PMC article.
Mutation of TGFβ-RII eliminates NSAID cancer chemoprevention.
Martín-López J, Gasparini P, Coombes K, Croce CM, Boivin GP, Fishel R. Martín-López J, et al. Oncotarget. 2017 Dec 31;9(16):12554-12561. doi: 10.18632/oncotarget.23792. eCollection 2018 Feb 27. Oncotarget. 2017. PMID: 29560090 Free PMC article.
44 results